Page 3 - சனா உயிரி தொழில்நுட்பவியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sana Announces Upsized Pricing of Initial Public Offering SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the pricing of its upsized initial public offering of 23,500,000 shares of its common stock at a public offering price of $25.00 per share. All of the shares of common stock are being offered by Sana. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sana, are expected to be $587.5 million. Sana’s common stock is expected to begin trading on The Nasdaq Global Select Market on February 4, 2021, under the ticker symbol “SANA.” The offering is expected to close on February 8, 2021, subject to the satisfaction of customary closing conditions. In addition, Sana has granted the underwriters a 30-day option to purchase up to an additional 3,525,000 shares of common s

New yorkUnited statesUnited kingdomNicole keithExchange commissionMorgan stanleyProspectus departmentBroadridge financial solutionsSana biotechnology incJp morgan securitiesGoldman sachs coSana biotechnologyNasdaq global select marketGoldman sachsBofa securitiesIsland avenue